Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
Seiji Takashio(Kumamoto University), Chisato Izumi(National Cerebral and Cardiovascular Center), Satoshi Yasuda(Tohoku University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Yasuaki Nakagawa(Kyoto Medical Center), Naoto Minamino(National Cerebral and Cardiovascular Center), Yasuhiro Hamatani(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University), Toshihisa Anzai(Hokkaido University), Chiaki Nagai‐Okatani(National Cerebral and Cardiovascular Center), Atsushi Okada(National Cerebral and Cardiovascular Center), Kenji Kangawa(National Cerebral and Cardiovascular Center), Makoto Amaki(National Cerebral and Cardiovascular Center), Masashi Amano(National Cerebral and Cardiovascular Center), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Tomohiro Hayashi(National Cerebral and Cardiovascular Center), Ayaka Matsuo(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University)
Cited by 9
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
<i>Bacteroides vulgatus</i> and <i>Bacteroides dorei</i> Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis
|Circulation|2018|627
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483